90 related articles for article (PubMed ID: 27650540)
1. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.
Verdura S; Encinar JA; Gratchev A; Llop-Hernández À; López J; Serrano-Hervás E; Teixidor E; López-Bonet E; Martin-Castillo B; Micol V; Bosch-Barrera J; Cuyàs E; Menendez JA
Phytomedicine; 2024 Jun; 128():155493. PubMed ID: 38484626
[TBL] [Abstract][Full Text] [Related]
2. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative activities of sinigrin on carcinogen-induced hepatotoxicity in rats.
Jie M; Cheung WM; Yu V; Zhou Y; Tong PH; Ho JW
PLoS One; 2014; 9(10):e110145. PubMed ID: 25329483
[TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Sell S
Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
[TBL] [Abstract][Full Text] [Related]
5. Hepatoregenerative role of bone morphogenetic protein-9.
Sosa I; Cvijanovic O; Celic T; Cuculic D; Crncevic-Orlic Z; Vukelic L; Zoricic Cvek S; Dudaric L; Bosnar A; Bobinac D
Med Sci Monit; 2011 Dec; 17(12):HY33-5. PubMed ID: 22129908
[TBL] [Abstract][Full Text] [Related]
6. BMP signaling and its paradoxical effects in tumorigenesis and dissemination.
Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J
Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009
[TBL] [Abstract][Full Text] [Related]
7. Rethinking growth factors: the case of BMP9 during vessel maturation.
Medina-Jover F; Riera-Mestre A; Viñals F
Vasc Biol; 2022 Feb; 4(1):R1-R14. PubMed ID: 35350597
[TBL] [Abstract][Full Text] [Related]
8. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
Ayuso-Íñigo B; Méndez-García L; Pericacho M; Muñoz-Félix JM
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771575
[TBL] [Abstract][Full Text] [Related]
9. SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma.
Wu J; Zhang M; Faruq O; Zacksenhaus E; Chen W; Liu A; Chang H
Biomark Res; 2021 Jun; 9(1):48. PubMed ID: 34134766
[TBL] [Abstract][Full Text] [Related]
10. New insights into BMP9 signaling in liver diseases.
Jiang QQ; Liu BB; Xu KS
Mol Cell Biochem; 2021 Oct; 476(10):3591-3600. PubMed ID: 34019202
[TBL] [Abstract][Full Text] [Related]
11. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells.
Zhang X; Zhu Y
Onco Targets Ther; 2021; 14():917-927. PubMed ID: 33603396
[TBL] [Abstract][Full Text] [Related]
12. Advances in Liver Cancer Stem Cell Isolation and their Characterization.
Liu L; Borlak J
Stem Cell Rev Rep; 2021 Aug; 17(4):1215-1238. PubMed ID: 33432485
[TBL] [Abstract][Full Text] [Related]
13. The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer.
Dituri F; Cossu C; Mancarella S; Giannelli G
Cells; 2019 Sep; 8(10):. PubMed ID: 31547567
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.
Ke J; Wu R; Chen Y; Abba ML
Am J Transl Res; 2018; 10(12):3887-3910. PubMed ID: 30662638
[TBL] [Abstract][Full Text] [Related]
15. Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells.
Wang Y; Yang B; Zhao J; Yu X; Liu X; Zhang L; Zhang Y; Li X; Zhai Z
Mol Med Rep; 2019 Mar; 19(3):1501-1508. PubMed ID: 30628686
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
17. Derivate isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis.
Chen L; Tian H; Li M; Ge C; Zhao F; Zhang L; Li H; Liu J; Wang T; Yao M; Li J
Tumour Biol; 2016 May; 37(5):5951-61. PubMed ID: 26596832
[TBL] [Abstract][Full Text] [Related]
18. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
